Soligenix, Inc. Common Stock (SNGX) is a publicly traded Healthcare sector company. As of July 22, 2026, SNGX trades at $0.37 with a market cap of $5.31M and a P/E ratio of -0.17. SNGX moved +1.56% today. Year to date, SNGX is -72.83%; over the trailing twelve months it is -73.81%. Its 52-week range spans $0.28 to $6.23. Analyst consensus is buy with an average price target of $1.50. Rallies surfaces SNGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SNGX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.37 |
| Market Cap | $5.31M |
| P/E Ratio | -0.17 |
| EPS | $-2.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.23 |
| 52-Week Low | $0.28 |
| Volume | 182.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.08M |
| Gross Margin | 0.00% |
1 analysts cover SNGX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.50.